- Home
- PRQR vs GGT Comparison
PRQR vs GGT Comparison
Compare PRQR & GGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PRQR | GGT |
|---|---|---|
| Founded | 2012 | 1994 |
| Country | | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 163.3M | 145.5M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | PRQR | GGT |
|---|---|---|
| Price | $1.45 | $4.04 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $7.67 | N/A |
| AVG Volume (30 Days) | ★ 408.8K | 59.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 15.56% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.83 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $18.44 | N/A |
| P/E Ratio | ★ N/A | $6.90 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.07 | $4.32 |
| 52 Week High | $3.10 | $7.00 |
Technical Indicators
Market Signals| Indicator | PRQR | GGT |
|---|---|---|
| Relative Strength Index (RSI) | 35.51 | 37.51 |
| Support Level | $1.33 | $4.15 |
| Resistance Level | $1.54 | $4.30 |
| Average True Range (ATR) | 0.09 | 0.06 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 31.94 | 3.57 |
Price Performance
Historical ComparisonAbout PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.
About GGT Gabelli Multi-Media Trust Inc. (The)
Gabelli Multimedia Trust Inc is a non-diversified closed-end management investment company. Its investment objective is the long-term growth of capital with income as a secondary objective. The fund invests majority of its assets, under normal market conditions, in common stock and other securities, including convertible securities, preferred stock, options, and warrants of companies in the telecommunications, media, publishing, and entertainment industries.